摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

((2R,3S,5R)-3-(4-chlorobenzoyloxy)-5-(4-(5-(3,4-dimethoxyphenyl)-6-methoxy-3-methylpyrazin-2-yl)-1H-1,2,3-triazol-1-yl)tetrahydrofuran-2-yl)methyl 4-chlorobenzoate | 1262486-53-2

中文名称
——
中文别名
——
英文名称
((2R,3S,5R)-3-(4-chlorobenzoyloxy)-5-(4-(5-(3,4-dimethoxyphenyl)-6-methoxy-3-methylpyrazin-2-yl)-1H-1,2,3-triazol-1-yl)tetrahydrofuran-2-yl)methyl 4-chlorobenzoate
英文别名
[(2R,3S,5R)-3-(4-chlorobenzoyl)oxy-5-[4-[5-(3,4-dimethoxyphenyl)-6-methoxy-3-methylpyrazin-2-yl]triazol-1-yl]oxolan-2-yl]methyl 4-chlorobenzoate
((2R,3S,5R)-3-(4-chlorobenzoyloxy)-5-(4-(5-(3,4-dimethoxyphenyl)-6-methoxy-3-methylpyrazin-2-yl)-1H-1,2,3-triazol-1-yl)tetrahydrofuran-2-yl)methyl 4-chlorobenzoate化学式
CAS
1262486-53-2
化学式
C35H31Cl2N5O8
mdl
——
分子量
720.566
InChiKey
FFECDMFSEYWEQO-FRXPANAUSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    6.1
  • 重原子数:
    50
  • 可旋转键数:
    13
  • 环数:
    6.0
  • sp3杂化的碳原子比例:
    0.26
  • 拓扑面积:
    146
  • 氢给体数:
    0
  • 氢受体数:
    12

反应信息

点击查看最新优质反应信息

文献信息

  • An Expeditious Route toward Pyrazine-Containing Nucleoside Analogues
    作者:Sachin G. Modha、Jalpa C. Trivedi、Vaibhav P. Mehta、Denis S. Ermolat’ev、Erik V. Van der Eycken
    DOI:10.1021/jo102089h
    日期:2011.2.4
    An improved and convenient methodology for the synthesis of asymmetrically substituted pyrazines starting from 3,5-dichloropyrazin-2(1H)-ones has been elaborated. Several nucleoside analogues have been synthesized containing the pyrazine core as the organic base coupled with the sugar via a triazole linkage. The beneficial effect of microwave irradiation throughout the sequence has been demonstrated.
  • Efficient Preparation of Tetrasubstituted Pyrazines Starting from Pyrazin-2(1H)-ones
    作者:Erik Van der Eycken、Sachin Modha、Jalpa Trivedi、Vaibhav Mehta、Denis Ermolat'ev
    DOI:10.1055/s-0031-1289714
    日期:2012.6
    methodology for the synthesis of tetrasubstituted pyrazines starting from pyrazin-2(1H)-ones has been elaborated. Diversity in the functionalization and the beneficial effect of microwave irradiation throughout the methodology has been demonstrated. palladium catalysis - copper catalysis - pyrazines - 3,5-dichloropyrazin-2(1H)-ones - microwaves - nucleosides
    已经阐述了一种从吡嗪-2(1 H)-ones开始合成四取代吡嗪的有效方法。在整个方法中,微波辐射的功能化和有益作用的多样性已得到证明。 钯催化-铜催化-吡嗪-3,5-二氯吡嗪-2(1 H)-ones-微波-核苷
查看更多

同类化合物

利巴韦林杂质G 利巴韦林杂质E 利巴韦林杂质B 利巴韦林 利巴韦林 三氮唑核苷脒盐酸盐 三氮唑核苷羧酸 三氮唑核苷5'-氨基磺酸 三氮唑核苷-5'-磷酸酯 三氮唑核苷 5'-二磷酸酯 三氮唑核苷 5'-三磷酸酯 三氮唑核苷 2',3',5'-三乙酸酯 三乙酰利巴韦林甲酯 [5-(3-氨基-1,2,4-三唑-1-基)-3,4-二苯甲酰氧基-四氢呋喃-2-基]甲基苯甲酸酯 [(2R,3S,4R,5R)-5-(3-硫代氨基甲酰-1,2,4-三唑-1-基)-3,4-二羟基四氢呋喃-2-基]甲基氨基磺酸 [(2R,3S,4R,5R)-5-(3-氨基羰基-1,2,4-三唑-1-基)-3,4-二羟基-四氢呋喃-2-基]甲基二氢磷酸酯与N,N-二乙基乙胺的化合物 5-氨基-1-[(2R,3R,4S,5R)-3,4-二羟基-5-(羟基甲基)四氢呋喃-2-基]-1,2,4-三唑-3-甲脒盐酸盐 5'-O-吡喃葡萄糖基三氮唑核苷 5'-O-吡喃半乳糖基三氮唑核苷 3-氰基-1-(2,3,5-三-O-乙酰基-beta-D-呋喃核糖基)-1,2,4-三唑 2’,3’-异亚丙基三氮唑核苷 2',3'-异亚丙基α-利巴韦林 2'-脱氧三氮唑核苷 1-Β-D-呋喃核糖基-1H-1,2,4-三氮唑-3-羧酸甲酯 1-[2,3-O-异亚丙基-beta-D-呋喃核糖基]-1,2,4-三唑-3-羧酸甲酯 1-[(2S,3S,4S,5S)-3,4-二羟基-5-(羟基甲基)四氢呋喃-2-基]-1,2,4-三唑-3-甲酰胺 1-[(2R,3R,4R,5R)-3,4-二丁氧基-5-(丁氧基甲基)四氢呋喃-2-基]-1,2,4-三唑-3-甲酰胺 1-(2-C-甲基-BETA-D-呋喃核糖基)-1H-1,2,4-三唑-3-甲酰胺 (2R,3S,4R,5R)-2-(羟基甲基)-5-[3-(甲氧基亚胺甲酰基)-1,2,4-三唑-1-基]四氢呋喃-3,4-二醇 (2R,3R,4S,5R)-2-[3-(乙氧基亚胺甲酰基)-1,2,4-三唑-1-基]-5-(羟基甲基)四氢呋喃-3,4-二醇 N1-(2,3,5-tri-O-benzoyl-β-D-ribofuranosyl)-C4-(coumarin-7-oxymethyl)-1,2,3-triazole 4,5-dibromo-1-(5-O-sulfamoyl-β-D-ribofuranosyl)triazole (2R,3R,4S,5R)-3'-(2-fluorophenyl)-5-(hydroxymethyl)-4,5-dihydro-3H,4'H,6'H-spiro[furan-2,7'-[1,2,3]triazolo[5,1-c][1,4]oxazine]-3,4-diol 4-((1-(β-D-ribofuranos-1-yl)-1,2,3-triazol-4-yl)methoxy)-2-phenylquinazoline ribavirin-5’-O-bis(benzoxy-L-alaninyl)phoshate 1-(5-deoxy-5-N-phosphonomethylamino-β-D-ribofuranosyl)-1,2,4-triazole-3-carboxamide (2R,3R,4S,5R)-3'-(4-chlorophenyl)-5-(hydroxymethyl)-4,5-dihydro-3H,4'H,6'H-spiro[furan-2,7'-[1,2,3]triazolo[5,1-c][1,4]oxazine]-3,4-diol 1-(4'-azido-2'-deoxy-2'-fluoro-β-D-arabinofuranosyl)-4-cyclopropyl-[1,2,3]-triazole 1-(5-O-thiophosphoryl-β-D-ribofuranosyl)-1,2,4-triazole-3-carboxamide 5-[2-(4-chlorophenyl)ethynyl]-1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2,4-triazole-3-carboxamide 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-[2-(1-methylimidazol-4-yl)ethynyl]-1,2,4-triazole-3-carboxamide 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-[2-[2-(trifluoromethyl)phenyl]ethynyl]-1,2,4-triazole-3-carboxamide 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-[2-(4-methylphenyl)ethynyl]-1,2,4-triazole-3-carboxamide 5-(4-trifluoromethylphenylethynyl)-1-(2,3,5-tri-hydroxy-β-D-ribofuranosyl)-1H-[1,2,4]triazole-3-carboxylic acid amide 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-(2-phenylethynyl)-1,2,4-triazole-3-carboxamide 5-(5-chloropent-1-ynyl)-1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2,4-triazole-3-carboxamide 5-(3-trifluoromethyl-phenylethynyl)-1-(2,3,5-tri-hydroxy-β-D-ribofuranosyl)-1H-[1,2,4]triazole-3-carboxylic acid amide 5-(thiophen-3-ylethynyl)-1-(2,3,5-tri-hydroxy-β-D-ribofuranosyl)-1H-[1,2,4]triazole-3-carboxylic acid amide 5-(4-methoxyphenylethynyl)-1-(2,3,5-tri-hydroxy-β-D-ribofuranosyl)-1H-[1,2,4]triazole-3-carboxylic acid amide 4-tetradecyloxymethyl-1-(β-D-arabinofuranosyl)-1,2,3-triazole